Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Similar articles for PubMed (Select 24283115)

1.

Fondaparinux in heparin-induced thrombocytopenia.

Gevaert A, Smets H, Vercauteren R.

Acta Cardiol. 2013 Oct;68(5):517-20.

PMID:
24283115
2.

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

Tvito A, Bakchoul T, Rowe JM, Greinacher A, Ganzel C.

Am J Hematol. 2015 Jul;90(7):675-8. doi: 10.1002/ajh.23971. Epub 2015 Feb 27. No abstract available.

PMID:
25683147
3.

Pulmonary embolism and heparin-induced thrombocytopenia successfully treated with tissue plasminogen activator and argatroban.

Hourmouzis Z, Bhalla MC, Frey JA, Jwayyed S.

Am J Emerg Med. 2015 May;33(5):739.e5-6. doi: 10.1016/j.ajem.2014.11.027. Epub 2014 Nov 28. No abstract available.

PMID:
25497698
4.

First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.

Ng HJ, Than H, Teo EC.

Thromb Res. 2015 Jan;135(1):205-7. doi: 10.1016/j.thromres.2014.06.005. Epub 2014 Jun 14. No abstract available.

PMID:
24974053
5.

Voting with your fondaparinux.

Warkentin TE.

Thromb Res. 2014 Jul;134(1):3-4. doi: 10.1016/j.thromres.2014.03.045. Epub 2014 Apr 1. No abstract available.

PMID:
24787988
6.

Fondaparinux Monitoring: Need for a Local Fondaparinux-Calibrated Anti-F actor Xa Assay.

Johnson PN, Benefield EC, Bui PY, Gausman JN, Marlar RA, Gessouroun MR.

J Pediatr Pharmacol Ther. 2013 Oct;18(4):318-9. doi: 10.5863/1551-6776-18.4.318. No abstract available.

7.

Heparin-induced thrombocytopenia in a patient with colon cancer.

Koul AN, Ahad R.

Indian J Med Paediatr Oncol. 2013 Oct;34(4):336-7. doi: 10.4103/0971-5851.125267. No abstract available.

8.

Treatment failure of low molecular weight heparin bridging therapy after implantation of a permanent pacemaker.

Giugno V, Messina F, Crosca S.

Int J Cardiol. 2014 May 15;173(3):e23-4. doi: 10.1016/j.ijcard.2014.01.094. Epub 2014 Jan 24. No abstract available.

PMID:
24491865
9.

An unusual presentation of heparin-induced thrombocytopenia in the setting of catheter-directed ablation of atrial fibrillation.

Vaidya R, Pruthi R, Thompson C.

Blood Coagul Fibrinolysis. 2014 Mar;25(2):188-90. doi: 10.1097/MBC.0000000000000016.

PMID:
24300023
10.

Response.

Williamson DR, Albert M, Heels-Ansdell D, Cook D; PROTECT Collaborators.

Chest. 2013 Dec;144(6):1979-80. doi: 10.1378/chest.13-2111. No abstract available.

PMID:
24297148
11.

Thrombocytopenia and thromboprophylaxis: a difficult combination?

Thachil J.

Chest. 2013 Dec;144(6):1979. doi: 10.1378/chest.13-1808. No abstract available.

PMID:
24297147
12.

Unfractionated heparin versus low-molecular-weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.

Ang E.

Clin Nurse Spec. 2013 Sep-Oct;27(5):229-30. doi: 10.1097/NUR.0b013e3182a0ba2b. Review. No abstract available.

PMID:
23942101
13.

Fondaparinux: an effective bridging strategy in heparin-induced thrombocytopenia and mechanical circulatory support.

Gellatly RM, Leet A, Brown KE.

J Heart Lung Transplant. 2014 Jan;33(1):118. doi: 10.1016/j.healun.2013.07.015. Epub 2013 Aug 9. No abstract available.

PMID:
23937882
14.

Treatment failure of low molecular weight heparin in diabetic patient.

Tulino D, Imbalzano E, Casale M, D'Angelo M, Coglitore S, Di Bella G, Dattilo G.

Int J Cardiol. 2013 Sep 30;168(2):e63-4. doi: 10.1016/j.ijcard.2013.07.064. Epub 2013 Jul 23. No abstract available.

PMID:
23890903
15.

Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.

[No authors listed]

Prescrire Int. 2013 Apr;22(137):99-101, 103-4. Review.

PMID:
23662321
16.

Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation.

Mahieu E, Claes K, Jacquemin M, Evenepoel P, Op De Beek K, Bogaert AM, Kuypers D, Verhamme P, Meijers B.

Artif Organs. 2013 May;37(5):482-7. doi: 10.1111/aor.12002. Epub 2013 Mar 5.

PMID:
23461610
17.

Nonheparin anticoagulants for heparin-induced thrombocytopenia.

Kelton JG, Arnold DM, Bates SM.

N Engl J Med. 2013 Feb 21;368(8):737-44. doi: 10.1056/NEJMct1206642. Review. No abstract available.

PMID:
23425166
18.

Effects of argatroban, danaparoid, and fondaparinux on trombin generation in heparin-induced thrombocytopenia.

Tardy-Poncet B, Combe M, Piot M, Chapelle C, Akrour M, Tardy B.

Thromb Haemost. 2013 Mar;109(3):504-9. doi: 10.1160/TH12-05-0321. Epub 2013 Jan 17.

PMID:
23328916
19.
20.

[Fondaparinux as an alternative anticoagulant in heparin-induced thrombocytopenia in the patient with a ventricular assist device].

Cegarra-Sanmartín V, Paniagua P, Galán J, Muñoz C, Moral MV.

Rev Esp Anestesiol Reanim. 2013 Nov;60(9):531-4. doi: 10.1016/j.redar.2012.09.006. Epub 2012 Nov 13. Spanish.

PMID:
23153592
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk